Our findings are consistent with previous studies that reported temozolomide is more beneficial in patients with MGMT methylated glioblastoma than in those with MGMT unmethylated glioblastoma.17–20 There is evidence supporting the biological mechanism of this observation. The gene discussed is MGMT; the disease is glioblastoma.